Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 18, 2026 07:30 ET | Source: Dragonfly Energy Holdings Corp.

Dragonfly Energy Strengthens IP Portfolio for Solid-State Battery Manufacturing with U.S. Patent Allowance

RENO, Nev., June 18, 2026 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and maker of Battle Born...
June 18, 2026 07:30 ET | Source: PMGC Holdings Inc.

NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets

NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets
June 18, 2026 07:00 ET | Source: Cervomed

CervoMed Secures New U.S. Patent Protecting Use of Neflamapimod in Pure Dementia with Lewy Body Patients into 2042

BOSTON, June 18, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today...
June 16, 2026 09:00 ET | Source: Oncolytics Biotech, Inc.

Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044

Oncolytics Biotech announced that the USPTO has issued a new patent broadly protecting the proprietary manufacturing process for pelareorep into 2044.
June 16, 2026 08:00 ET | Source: Cingulate Inc.

Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301

KANSAS CITY, Kan., June 16, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
June 16, 2026 07:30 ET | Source: Cognition Therapeutics, Inc.

Cognition Therapeutics Announces New Composition of Matter Patent, Extending Patent Protection for Lead Candidate, Zervimesine (CT1812) Through 2045

PURCHASE, N.Y., June 16, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative...
June 16, 2026 07:07 ET | Source: Pluristyx, Inc.

Pluristyx Announces Patent Allowance of Next Generation Synthetic mRNA Technology in Japan, Solidifying Global iPSC Reprogramming Leadership

Pluristyx issued Japan patent allowance for next-gen synthetic mRNA, accelerating non-viral, footprint-free iPSC generation for regenerative medicine
June 16, 2026 06:30 ET | Source: InterDigital, Inc.

InterDigital awarded injunction against Disney by Unified Patent Court

WILMINGTON, Del., June 16, 2026 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a wireless, video and AI technology research and development company, today announced it has been awarded...
June 16, 2026 06:00 ET | Source: Beam Global

Beam Global Granted European Patent for Smart Battery Solutions

Beam Global granted European patent EP 4 348 756 B1 for Smart PCC™ battery thermal management technology, strengthening IP protection across Europe.
June 15, 2026 10:31 ET | Source: Roadzen Inc.

Roadzen Subsidiary drivebuddyAI Granted Patent for Real-Time Lane Detection System; Demonstrates Technology at InCabin Detroit 2026

WILMINGTON, Del., June 15, 2026 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN), a global leader in AI at the convergence of insurance and mobility, today announced that its fleet safety subsidiary...